Equities research analysts at StockNews.com initiated coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the spec… [+2190 chars]...
Read moreEvoke Pharma (NASDAQ:EVOK – Get Free Report) is expected to release its Q1 2025 earnings data before the market opens on Tuesday, May 13th. Analysts expect Evoke Pharma to post earnings of ($0.33) pe… [+1758 chars]...
Read moreResearch analysts at StockNews.com assumed coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “se… [+2106 chars]...
Read moreQ1 2025 Net Product Sales Increased 77% Year-over-Year to $3.1 Million Sustained Momentum Driven by Growing Prescriber Adoption and Repeat Patient Use SOLANA BEACH, Calif., May 13, 2025 (GLOBE NEWS… [+16533 chars]...
Read moreWhile writing this article, I did my best to really concentrate my effort to make it as sharp and as impactful as I could. But I kept getting distracted checking work messengers and swiping away endl… [+7142 chars]...
Read more